Home / Quinapril / United States
US ATC C09AA06 · updated 2 Nov 2026
Quinapril shortage in United States
Is there a Quinapril shortage in United States?
Yes. As of 2 Nov 2026, 16 Quinapril products are reported short in United States, the first since 19 Jan 2023. No return date has been given. Main reason: manufacturing problem.
Also short in Canada. All countries.
Affected products in United States
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| US | Quinapril Hydrochloride, Tablet, 10 mg (NDC 43547-411-09) | Solco Healthcare US, LLC | 19 Jan 2023 | not given | Active ingredient shortage Shortage of an active ingredient |
| US | Quinapril Hydrochloride, Tablet, 10 mg (NDC 62135-485-90) | Chartwell Molecular Holdings LLC | 19 Jan 2023 | not given | Not stated |
| US | Quinapril Hydrochloride, Tablet, 10 mg (NDC 65862-618-90) discontinuation | Aurobindo Pharma USA | 19 Jan 2023 | not given | Manufacturing problem Discontinuation of the manufacture of the drug |
| US | Quinapril Hydrochloride, Tablet, 10 mg (NDC 65862-618-90) discontinuation | Aurobindo Pharma USA | 19 Jan 2023 | not given | Manufacturing problem Discontinuation of the manufacture of the drug |
| US | Quinapril Hydrochloride, Tablet, 10 mg (NDC 68180-557-09) | Lupin Pharmaceuticals, Inc. | 19 Jan 2023 | not given | Manufacturing problem Requirements related to complying with good manufacturing practices |
| US | Quinapril Hydrochloride, Tablet, 20 mg (NDC 43547-412-09) | Solco Healthcare US, LLC | 19 Jan 2023 | not given | Active ingredient shortage Shortage of an active ingredient |
| US | Quinapril Hydrochloride, Tablet, 20 mg (NDC 62135-486-90) | Chartwell Molecular Holdings LLC | 19 Jan 2023 | not given | Not stated |
| US | Quinapril Hydrochloride, Tablet, 20 mg (NDC 68180-558-09) | Lupin Pharmaceuticals, Inc. | 19 Jan 2023 | not given | Manufacturing problem Requirements related to complying with good manufacturing practices |
| US | Quinapril Hydrochloride, Tablet, 40 mg (NDC 43547-413-09) | Solco Healthcare US, LLC | 19 Jan 2023 | not given | Active ingredient shortage Shortage of an active ingredient |
| US | Quinapril Hydrochloride, Tablet, 40 mg (NDC 62135-487-90) | Chartwell Molecular Holdings LLC | 19 Jan 2023 | not given | Not stated |
| US | Quinapril Hydrochloride, Tablet, 40 mg (NDC 65862-620-90) discontinuation | Aurobindo Pharma USA | 19 Jan 2023 | not given | Manufacturing problem Discontinuation of the manufacture of the drug |
| US | Quinapril Hydrochloride, Tablet, 40 mg (NDC 68180-554-09) | Lupin Pharmaceuticals, Inc. | 19 Jan 2023 | not given | Manufacturing problem Requirements related to complying with good manufacturing practices |
| US | Quinapril Hydrochloride, Tablet, 5 mg (NDC 43547-410-09) | Solco Healthcare US, LLC | 19 Jan 2023 | not given | Active ingredient shortage Shortage of an active ingredient |
| US | Quinapril Hydrochloride, Tablet, 5 mg (NDC 62135-484-60) | Chartwell Molecular Holdings LLC | 19 Jan 2023 | not given | Not stated |
| US | Quinapril Hydrochloride, Tablet, 5 mg (NDC 65862-617-90) discontinuation | Aurobindo Pharma USA | 19 Jan 2023 | not given | Manufacturing problem Discontinuation of the manufacture of the drug |
| US | Quinapril Hydrochloride, Tablet, 5 mg (NDC 68180-556-09) | Lupin Pharmaceuticals, Inc. | 19 Jan 2023 | not given | Manufacturing problem Requirements related to complying with good manufacturing practices |
Source
U.S. Food and Drug Administration (FDA), Drug Shortages via openFDA. Official list. Shortages the FDA lists as current, plus products to be discontinued; one row per package (NDC).